Literature DB >> 26215512

Management of hypertension in chronic kidney disease.

Raymond R Townsend1, Sandra J Taler2.   

Abstract

Hypertension is a common comorbidity in patients with impaired kidney function. The kidney exerts a marked degree of control over blood pressure through various mechanisms, such as by regulating sodium balance and hormone secretion through the activity of the renin-angiotensin system. The kidney is susceptible to injury, and if already damaged can be at risk of further loss of function as a consequence of elevated blood pressure. Once elevated blood pressure is identified, a combination of sensible lifestyle measures, such as sodium restriction and weight loss, with pharmacological intervention to reduce blood pressure will usually achieve blood pressure goals. In this Review, we outline the importance of blood pressure control for patients with chronic kidney disease (CKD), the mechanisms that affect blood pressure control, and the basis for non-drug and drug therapies. We further discuss the rationale for <140 mmHg systolic and <90 mmHg diastolic targets for blood pressure in patients with CKD, with consideration for tighter targets in the setting of proteinuria.

Entities:  

Mesh:

Year:  2015        PMID: 26215512     DOI: 10.1038/nrneph.2015.114

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  120 in total

1.  Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension.

Authors:  T Uzu; G Kimura
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

2.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

3.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

4.  Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

Authors:  John D Bisognano; George Bakris; Mitra K Nadim; Luis Sanchez; Abraham A Kroon; Jill Schafer; Peter W de Leeuw; Domenic A Sica
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

5.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 6.  The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.

Authors:  J H Laragh; J E Sealey; F R Bühler; E D Vaughan; H R Brunner; H Gavras; L Baer
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965

7.  Blood pressure control by home monitoring: meta-analysis of randomised trials.

Authors:  Francesco P Cappuccio; Sally M Kerry; Lindsay Forbes; Anna Donald
Journal:  BMJ       Date:  2004-06-11

Review 8.  Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.

Authors:  Feras Karadsheh; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 9.  Hypertension management in patients with chronic kidney disease.

Authors:  Biff F Palmer
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

Review 10.  Vascular actions of aldosterone.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  J Vasc Res       Date:  2012-11-21       Impact factor: 1.934

View more
  27 in total

Review 1.  Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients.

Authors:  Caixia Wang; Xilian Qiu; Linsheng Lv; Jianhua Huang; Shaomin Li; Tanqi Lou; Xun Liu
Journal:  Int Urol Nephrol       Date:  2016-11-14       Impact factor: 2.370

2.  Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation.

Authors:  Xiao Li Zhan; Xiu Hong Yang; Yan Hong Gu; Li Li Guo; Hui Min Jin
Journal:  Mol Cell Biochem       Date:  2017-09-04       Impact factor: 3.396

Review 3.  Soy-based renoprotection.

Authors:  Nancy J McGraw; Elaine S Krul; Elizabeth Grunz-Borgmann; Alan R Parrish
Journal:  World J Nephrol       Date:  2016-05-06

4.  Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.

Authors:  Paul E Drawz; Roland Brown; Luca De Nicola; Naohiko Fujii; Francis B Gabbai; Jennifer Gassman; Jiang He; Satoshi Iimuro; James Lash; Roberto Minutolo; Robert A Phillips; Kyle Rudser; Luis Ruilope; Susan Steigerwalt; Raymond R Townsend; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-05       Impact factor: 8.237

5.  A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.

Authors:  Rajiv Saran; Robin L Padilla; Brenda W Gillespie; Michael Heung; Scott L Hummel; Vimal Kumar Derebail; Bertram Pitt; Nathan W Levin; Fansan Zhu; Samer R Abbas; Li Liu; Peter Kotanko; Philip Klemmer
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 8.237

Review 6.  Management of Hypertension in Patients with Chronic Kidney Disease.

Authors:  Seyed Mehrdad Hamrahian
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 7.  The WNK signaling pathway and salt-sensitive hypertension.

Authors:  Taisuke Furusho; Shinichi Uchida; Eisei Sohara
Journal:  Hypertens Res       Date:  2020-04-14       Impact factor: 3.872

8.  Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation.

Authors:  Gregory J Weber; Jaleyea Foster; Sathnur B Pushpakumar; Utpal Sen
Journal:  Pharmacol Res       Date:  2018-06-15       Impact factor: 7.658

Review 9.  Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.

Authors:  Elvira O Gosmanova; Csaba P Kovesdy
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

10.  Prevalence of Homocysteine-Related Hypertension in Patients With Chronic Kidney Disease.

Authors:  Zengchun Ye; Cheng Wang; Qunzi Zhang; Yan Li; Jun Zhang; XinXin Ma; Hui Peng; Tanqi Lou
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.